Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Partial maturation: an immune-evasion strategy of dengue virus?

Rodenhuis-Zybert IA, Wilschut J, Smit JM.

Trends Microbiol. 2011 May;19(5):248-54. doi: 10.1016/j.tim.2011.02.002. Review.

PMID:
21388812
2.

Functional importance of dengue virus maturation: infectious properties of immature virions.

Zybert IA, van der Ende-Metselaar H, Wilschut J, Smit JM.

J Gen Virol. 2008 Dec;89(Pt 12):3047-51. doi: 10.1099/vir.0.2008/002535-0.

PMID:
19008392
3.

Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.

Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, Jairungsri A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N.

J Virol. 2004 Mar;78(5):2367-81.

4.

Immature dengue virus: a veiled pathogen?

Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei HY, Wilschut J, Smit JM.

PLoS Pathog. 2010 Jan;6(1):e1000718. doi: 10.1371/journal.ppat.1000718.

6.

Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2.

da Silva Voorham JM, Rodenhuis-Zybert IA, Ayala Nuñez NV, Colpitts TM, van der Ende-Metselaar H, Fikrig E, Diamond MS, Wilschut J, Smit JM.

PLoS One. 2012;7(3):e29957. doi: 10.1371/journal.pone.0029957.

7.

Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.

Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A, Saraithong P, Chaichoun K, Utaipat U, Keelapang P, Kanjanahaluethai A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N.

J Virol. 2008 Nov;82(21):10776-91. doi: 10.1128/JVI.01180-08.

8.

Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.

Wang PG, Kudelko M, Lo J, Siu LY, Kwok KT, Sachse M, Nicholls JM, Bruzzone R, Altmeyer RM, Nal B.

PLoS One. 2009 Dec 15;4(12):e8325. doi: 10.1371/journal.pone.0008325.

9.

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.

Fonseca BA, Pincus S, Shope RE, Paoletti E, Mason PW.

Vaccine. 1994;12(3):279-85. Erratum in: Vaccine 1994 Apr;12(5):480.

PMID:
8165861
10.

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.

Chambers TJ, Jiang X, Droll DA, Liang Y, Wold WS, Nickells J.

J Gen Virol. 2006 Nov;87(Pt 11):3131-40.

PMID:
17030845
11.

Antibodies against immature virions are not a discriminating factor for dengue disease severity.

Rodenhuis-Zybert IA, da Silva Voorham JM, Torres S, van de Pol D, Smit JM.

PLoS Negl Trop Dis. 2015 Mar 11;9(3):e0003564. doi: 10.1371/journal.pntd.0003564.

12.

Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry.

Hsieh SC, Wu YC, Zou G, Nerurkar VR, Shi PY, Wang WK.

J Biol Chem. 2014 Nov 28;289(48):33149-60. doi: 10.1074/jbc.M114.610428.

14.

A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.

De Paula SO, Lima DM, de Oliveira França RF, Gomes-Ruiz AC, da Fonseca BA.

Arch Virol. 2008;153(12):2215-23. doi: 10.1007/s00705-008-0250-3.

PMID:
19002647
15.

The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection.

Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, Yeh TM, Chen SH, Liu CC, Lei HY.

J Immunol. 2006 Mar 1;176(5):2825-32.

16.
17.

Immune response to synthetic peptides of dengue prM protein.

Vázquez S, Guzmán MG, Guillen G, Chinea G, Pérez AB, Pupo M, Rodriguez R, Reyes O, Garay HE, Delgado I, García G, Alvarez M.

Vaccine. 2002 Mar 15;20(13-14):1823-30.

PMID:
11906771
18.
19.

Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.

Mathenge EG, Parquet Mdel C, Funakoshi Y, Houhara S, Wong PF, Ichinose A, Hasebe F, Inoue S, Morita K.

J Gen Virol. 2004 Sep;85(Pt 9):2503-13.

PMID:
15302944
20.

Antigenic cell associated dengue 2 virus proteins detected in vitro using dengue fever patients sera.

Abubakar S, Azila A, Suzana M, Chang LY.

Malays J Pathol. 2002 Jun;24(1):29-36.

PMID:
16329553
Items per page

Supplemental Content

Support Center